Trinity Biotech | TRIB - Aktuelle Verpflichtungen





Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 18.38B 1.88B 2026-03
Bayer EUR 32.27B 1.19B 2026-06
Bio-Rad Laboratories USD 961.3M 44.3M 2026-06
EDAP TMS EUR 37.51M 6.1M 2026-03
J&J USD 54.9B 2.82B 2026-06
Mesa Laboratories USD 54.4M 6.1M 2025-12
OraSure Technologies USD 25.12M 18.96M 2026-06
Plus Therapeutics USD 8.57M 612K 2026-06
Roche Holding CHF 28.85B 846M 2026-06
Siemens EUR 45.11B 4.4B 2026-06
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Tosoh JPY 391.91B 37.39B 2026-06
Trinity Biotech USD 141.21M 106.72M 2025-12
Veracyte USD 62.74M 6.62M 2026-06